Correction

Accepted on 14 Nov 2024

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

in Cancer Immunity and Immunotherapy

Chenghao Fu
昊楠杜
Qiang Wang
Weiyou Zhu
Guangli Bian
Zhujuan Zhong
Yuheng Wang
Lei Cao

Frontiers in Immunology

doi 10.3389/fimmu.2024.1527232

Systematic Review

Accepted on 14 Nov 2024

Modular (universal) CAR-T Platforms in vivo: A Comprehensive Systematic Review

in Cancer Immunity and Immunotherapy

Afraa Mohammad
Anna A Yurina
Tatiana Robertovna Simonyan
Daniil Sergeevich Chistyakov
Rand Salman
Ksenia Zornikova
Elizaveta Petrovna Minina
Apollinariya Vassilyevna Bogolyubova

Frontiers in Immunology

doi 10.3389/fimmu.2024.1409665

Case Report

Accepted on 14 Nov 2024

Quantification of PD-L1 Expression and Tumor Mutational Burden in Biologically Distinct Advanced Pancreatic Cancers Responding to Pembrolizumab: Case Reports

in Cancer Immunity and Immunotherapy

Kevin Y Li
Andrew M Lowy
Paul Fanta

Frontiers in Immunology

doi 10.3389/fimmu.2024.1452543

Original Research

Accepted on 14 Nov 2024

In vivo Programmed Myeloid Cells Expressing Novel Chimeric Antigen Receptors Show Potent Anti-tumor Activity in Preclinical Solid Tumor Models

in Cancer Immunity and Immunotherapy

Shannon Argueta
Yuxiao Wang
Hongyun Zhao
Neha Diwanji
Michael Gorgievski
Edward Cochran
Ewa Grudzien-Nogalska
Josephine D'Alessandro
Bruce McCreedy
Thomas Prod'homme

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501365

Original Research

Accepted on 14 Nov 2024

Tocilizumab in Combination with Corticosteroids: Potential for Managing Cancer Cachexia with Systemic Hyperinflammation

in Cancer Immunity and Immunotherapy

Ping Chen
Dingyi Wang
Zhouwei Zhan
Ling Chen
Yu Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1477310

Case Report

Accepted on 14 Nov 2024

Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report

in Cancer Immunity and Immunotherapy

Chiara Bernardi
Yan Beauverd
Thien-An Tran
Marie Maulini
Maria Mappoura
Sarah Morin
Federico Simonetta
Anne Cairoli
Holger W Auner
Kaveh Samii

Frontiers in Immunology

doi 10.3389/fimmu.2024.1495233

Original Research

Accepted on 14 Nov 2024

Evaluating the Prognostic Potential of Telomerase Signature in Breast Cancer Through Advanced Machine Learning Model

in Cancer Immunity and Immunotherapy

Xiao Guo
Yuyan Cao
Xinlin Shi
Jiaying Xing
Chuanbo Feng
Tao Wang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1462953

Original Research

Published on 14 Nov 2024

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells

in Cancer Immunity and Immunotherapy

Jiao Qu
Yueqin Zhang
Cong Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1500998

186 views

Case Report

Published on 14 Nov 2024

Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT

in Cancer Immunity and Immunotherapy

Sujuan Chen
Mingchen Cai
Guirong Tan
Ruomi Guo
Qiong Liang
Hainan Li
Xiang Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1478163

267 views

Review

Published on 14 Nov 2024

The roles of cancer stem cells and therapeutic implications in melanoma

in Cancer Immunity and Immunotherapy

Xiaoli Mu
Yixin Zhou
Yongxin Yu
Mingyi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486680

147 views

Original Research

Published on 14 Nov 2024

Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML

in Cancer Immunity and Immunotherapy

Feng-Luan Zhong
Jia-Jun He
Kun-Hao Bai
Ruo-Nan Shao
Guo-Yan Wu
Xiao-Peng Tian
Da-Wei Wang
Yu-Jun Dai
Si-Liang Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1486592

334 views

Review

Accepted on 13 Nov 2024

Neutrophils in oncolytic virus immunotherapy

in Cancer Immunity and Immunotherapy

Danya Zhou
Chenglin Zhang
Jingyi Sun
Ming Yuan

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490414

Review

Accepted on 13 Nov 2024

IL-17A in gastric carcinogenesis: good or bad?

in Cancer Immunity and Immunotherapy

Weidong Li
Xiaodong Huang
Xiaowen Han
Jiayi Zhang
Lei Gao
Hao Chen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1501293

Review

Accepted on 13 Nov 2024

Dynamics of the Immune Microenvironment and Immune Cell PANoptosis in Colorectal Cancer: Recent Advances and Insights

in Cancer Immunity and Immunotherapy

Jinlong Wan
Jianzhong Zhao
Xiaolu Fang

Frontiers in Immunology

doi 10.3389/fimmu.2024.1502257

Review

Accepted on 13 Nov 2024

Siglec15 in Blood system diseases： from bench to bedside

in Cancer Immunity and Immunotherapy

Yu Jia Fan
Liangliang Sun
Juan He
Yutong Chen
Hongli Ma
Hai Tao Ding

Frontiers in Immunology

doi 10.3389/fimmu.2024.1490505

Original Research

Accepted on 13 Nov 2024

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer

in Cancer Immunity and Immunotherapy

Xiaofang Li
Zhiling Pan
Tiankuo Luan
Qian Xiao
Liuying Li
Qianxue Wu
Guoqing Yao
Xiang Zhang
Daqiang Song

Frontiers in Immunology

doi 10.3389/fimmu.2024.1493673

Navigation group

Articles

Corrigendum: Case report: A golden tail of immunotherapy: significant tail effect in a chemotherapy-resistant advanced pulmonary sarcomatoid carcinoma patient treated by Sintilimab combined with Anlotinib

Modular (universal) CAR-T Platforms in vivo: A Comprehensive Systematic Review

Quantification of PD-L1 Expression and Tumor Mutational Burden in Biologically Distinct Advanced Pancreatic Cancers Responding to Pembrolizumab: Case Reports

In vivo Programmed Myeloid Cells Expressing Novel Chimeric Antigen Receptors Show Potent Anti-tumor Activity in Preclinical Solid Tumor Models

Tocilizumab in Combination with Corticosteroids: Potential for Managing Cancer Cachexia with Systemic Hyperinflammation

Anti-BCMA and GPRC5D bispecific antibodies in relapsed/refractory primary plasma cell leukemia: a case report

Evaluating the Prognostic Potential of Telomerase Signature in Breast Cancer Through Advanced Machine Learning Model

Effects of resveratrol-loaded dendrimer nanomedicine on hepatocellular carcinoma cells

Case report: Intravascular large B cell lymphoma mimicking acute demyelinating encephalomyelitis after SARS-CoV-2 reinfection: diagnostic value of advanced MRI techniques and the literature review with the assistance of ChatGPT

The roles of cancer stem cells and therapeutic implications in melanoma

Tigecycline-induced coagulation gene prognostic prediction model and intestinal flora signature in AML

Neutrophils in oncolytic virus immunotherapy

IL-17A in gastric carcinogenesis: good or bad?

Dynamics of the Immune Microenvironment and Immune Cell PANoptosis in Colorectal Cancer: Recent Advances and Insights

Siglec15 in Blood system diseases： from bench to bedside

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer